REGISTERED
on 15 Jun 2021
Last Applicant/ Owned by
85748 Garching
DE
Serial Number
79295820 filed on 28th Jul 2020
Registration Number
6383044 registered on 15th Jun 2021
Filing Basis
No Filing Basis
Disclaimer
NO DATA
ITM
Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography [PET] or single photon emission tomography [SPECT], target radionuclide and peptide receptor radionuclide therapy [PRRT]; theranostics in the field of preci Read More
Classification Information
Class [005]
Pharmaceutical Products
Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography [PET] or single photon emission tomography [SPECT], target radionuclide and peptide receptor radionuclide therapy [PRRT]; theranostics in the field of precision oncology; radiopharmaceutical products, namely, lutetium-containing precursors for imaging and detection for diagnosing and monitoring cancer; solutions for radioactive labelling being medical diagnostic preparations; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing radioisotopes, e.g. lutetium-177, actinium-225, yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumours; target radiopharmaceuticals containing a target molecule, e.g. peptide or antibody, depending on the indication and a medical radioactive isotope for diagnosis purposes; radiopharmaceuticals containing gallium and its complexes, gallium-68 DOTATOC for treatment of cancer; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumours of gastroenteric or pancreatic origin [GEP-NET]; radiopharmaceuticals for use in the therapy of GEP-NET, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer; radiopharmaceuticals containing radioisotopes with short half-lives, such as gallium-68 or fluorine-18 for diagnostic applications; Radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as PET [positron emission tomography] or SPECT [single photon emission tomography], for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular lutetium-177, actinium-225 or yttrium-90 for the treatment of tumour diseases
Class [010]
Medical Instrument Products
Medical instruments, apparatus and containers for the application of radiopharmaceutical and radiodiagnostic preparations; controlling, regulating and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular apparatus for therapy and diagnosis with a radiotherapeutic or radiodiagnostic substance; radionuclide generators being medical instruments for radiopharmaceutical purposes
Class [042]
Computer & Software Services & Scientific Services
Conducting clinical trials for others at all stages and in various indications, particularly in oncology; conducting phase III clinical trials for others with target radiopharmaceutical 177Lu-Edotreotide in patients with neuroendocrine tumours of gastroenteric or pancreatic origin [GEP-NET]
Class [044]
Medical, Beauty & Agricultural Services
Medical services, in particular services relating to radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology and nuclear medicine and brachytherapies, including intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and target radionuclide therapy, peptide receptor radionuclide therapy [PRRT], personal nuclear medicine and precision oncology
Mark Details
Serial Number
No 79295820
Mark Type
No Service Mark
Attorney Docket Number
No 540.321US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.13 -
Two circles
26.01.21 -
Circles that are totally or partially shaded
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 26th Nov 2021 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| 15th Nov 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 21st Oct 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 30th Sep 2021 | GENERIC MADRID TRANSACTION SENT TO IB |
| 30th Sep 2021 | GENERIC MADRID TRANSACTION CREATED |
| 15th Sep 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 15th Jun 2021 | REGISTERED-PRINCIPAL REGISTER |
| 05th Apr 2021 | NOTIFICATION PROCESSED BY IB |
| 30th Mar 2021 | PUBLISHED FOR OPPOSITION |
| 30th Mar 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |